Recent development in studies of tetrahydroprotoberberines: Mechanism in antinociception and drug addiction

Cellular and Molecular Neurobiology

Volumn 28, Issue 4, 2008, Pages 491-499

  Chu, Hongyuan ^a   Jin, Guozhang ^a   Friedman, Eitan ^b   Zhen, Xuechu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Antinociception; Dopamine receptor; Drug addiction; l Stepholidine; l Tetrahydropalmatine; Tetrahydroprotoberberines

Indexed keywords

12 CHLOROSCOULERINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BERBINE DERIVATIVE; BETA ENDORPHIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; DYNORPHIN; ENDORPHIN; ENKEPHALIN; MORPHINE; OPIATE RECEPTOR; PROTEIN C FOS; QUINPIROLE; SPIPERONE; STEPHOLIDINE; TETRAHYDROPALMATINE;

ANALGESIC ACTIVITY; ANTINOCICEPTION; ARTICLE; COCAINE DEPENDENCE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG DEPENDENCE; DRUG MECHANISM; HUMAN; HYPERALGESIA; MOLECULAR DYNAMICS; NOCICEPTION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; WITHDRAWAL SYNDROME;

ANALGESICS; ANIMALS; BERBERINE; BERBERINE ALKALOIDS; DOPAMINE ANTAGONISTS; HUMANS; MODELS, BIOLOGICAL; PAIN; RECEPTORS, DOPAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 43149109280     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-007-9179-4     Document Type: Article

References (49)

1. Adinoff B (2004) Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 12:305-320
2. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, Carr K, Hall S (1996) Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347:504-508
3. Bittencourt AL, Takahashi RN (1997) Mazindol and lidocaine are antinociceptives in the mouse formalin model: involvement of dopamine receptor. Eur J Pharmacol 330:109-113
4. Chen LF, Gao JZ, Wang FC (1986) Analgesic and antipyretic effects of l-stepholidine without addiction. Zhongguo Yao Li Xue Bao 7:311-314
5. Coffin VL, Latranyi MB, Chipkin RE (1989) Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors. J Pharmacol Exp Ther 249:769-774
6. Frussa-Filho R, Rocha JB, Conceicao IM, Mello CF, Pereira ME (1996) Effects of dopaminergic agents on visceral pain measured by the mouse writhing test. Arch Int Pharmacodyn Ther 331:74-93
7. Gilbert A-K, Franklin KBJ (2001) Characterization of the analgesic properties of nomifensine in rats. Pharmacol Biochem Behav 68:783-787
8. Grech DM, Spealman RD, Bergman J (1996) Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology 125:97-104
9. Guo X, Wang LM, Liu J, Jin GZ (1997) Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf striatum. Zhongguo Yao Li Xue Bao 18:225-230
10. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143:102-110
11. Herz A, Millan MJ (1990) Opioids and opioid receptors mediating antinociception at various levels of the neuraxis. Physiol Bohemoslov 39:395-401
12. Hu JY, Jin GZ (1999a) Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain. Zhongguo Yao Li Xue Bao 20:193-200
13. Hu JY, Jin GZ (1999b) Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 20:715-719
14. Hu JY, Jin GZ (2000) Arcuate nucleus of hypothalamus involved in analgesic action of l-THP. Acta Pharmacol Sin 21:439-444
15. Huang KX, Jin GZ (1992) The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Sci China B 35:688-696
16. Huang KX, Sun BC, Jin GZ (1992) (-)-Stepholidine: a dopamine receptor antagonist shows agonistic effect on rotational behavior in 6-hydroxydopamine- lesioned rats. Zhongguo Yao Li Xue Bao 13:17-22
17. Jin GZ (1987) (-)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol Sci 8:81-82
18. Jin GZ (2001) Discoveries in the voyage of Corydalis research. Shanghai Scientific & Technical Publishers, Shanghai
19. Jin GZ, Huang KX, Sun BC (1992) Dual actions of (-)-stepholidine on dopamine receptor subtypes after substantia nigra lesion. Neurochem Int 20(Suppl):175S-178S
20. Jin GZ, Sun BC (1995) Neuropharmacological effects of (-)-stepholidine and its analogues on brain dopaminergic system. Adv Exp Med Biol 363:27-28
21. Jin GZ, Zhu ZT, Fu Y (2002) (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 23:4-7
22. Kin KC, Zhen XF, Hsu B (1964) Studies on the pharmacological action of Corydalis XII: the effects of isomers of tetrahydropalmatine(THP) on central nervous system. Acta Physiol Sin 27:47-57
23. Leshner AI (1997) Addiction is a brain disease, and it matters. Science 278:45-47
24. Liu ZH, Jin WQ, Zhang HP, Chen XJ, Jin GZ (2003) Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand. Pharmacol Biochem Behav 75:289-294
25. Magnusson JE, Fisher K (2000) The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum. Brain Res 855:260-266
26. Malhotra J, Chaudhary G, Gupta YK (2000) Dopaminergic involvement in adenosine A1 receptor-mediated antinociception in the tail flick latency model in mice. Methods Find Exp Clin Pharmacol 22:37-41
27. Mantsch JR, Li SJ, Risinger R, Awad S, Katz E, Baker DA, Yang Z (2007) Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats. Psychopharmacol (Berl) 192:581-591
28. McBride WJ, Murphy JM, Ikemoto S (1999) Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101:129-152
29. Michael BG, Negus SS, Nancy KM (1998) Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology 135:99-106
30. Pelissier T, Laurido C, Hernandez A, Constandil L, Eschalier A (2006) Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists. Eur J Pharmacol 546:40-47
31. Pierce RC, Kumaresan V (2006) The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30:215-238
32. Platt DM, Rowlett JK, Spealman RD (2000) Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther 293:1017-1026
33. Pulvirenti L, Koob GF (1994) Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 15:374-379
34. Roane DS, Bounds JK, Ang C-Y, Adloo AA (1998) Quinpirole-induced alterations of tail temperature appear as hyperalgesia in the radiant heat tail-flick test. Pharmacol Biochem Behav 59:77-82
35. Shimizu T, Iwata S-i, Morioka H, Masuyama T, Fukuda T, Nomoto M (2004) Antinociceptive mechanism of -DOPA. Pain 110:246-249
36. Spealman RD, Jack B, Rosenzweig-Lipson S (1997) Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacology 133:283-292
37. Taylor BK, Joshi C, Uppal H (2003) Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res 987:135-143
38. Wang W, Zhou Y, Sun J, Pan L, Kang L, Dai Z, Yu R, Jin G, Ma L (2007) The effect of l-stepholidine, a novel extract of Chinese herb, on the acquisition, expression, maintenance, and re-acquisition of morphine conditioned place preference in rats. Neuropharmacology 52:355-361
39. Warner EA, Kosten TR, O'Connor PG (1997) Pharmacotherapy for opioid and cocaine abuse. Medical Clin North Am 81:909-925
40. Weed MR, Paul IA, Dwoskin LP, Moore SE, Woolverton WL (1997) The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. J Pharmacol Exper Ther 283:29-38
41. Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22
42. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240
43. Xu J, Zheng LZ, Jin GZ (1982) Relevance of brain prostaglandins to central effects of l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 3:217-220
44. Xu SX, Yu LP, Han YR, Chen Y, Jin GZ (1989) Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xue Bao 10:104-110
45. Yang Z, Chen H, Hao W, Jin G, Li S (2006) Medication of L-tetrahydropalmatine increased the abstinence rate in heroin addicts. College on Problems of Drug Dependence 2006 Meeting Abstracts, Scottsdale, AZ, Available at http://biopsych.com:81/CPDD06_Web/MeetProgAbSearch_06.html
46. Yoshimura M, North RA (1983) Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin. Nature 305:529-530
47. Zarrindast M-R, Nassiri-Rad S, Pazouki M (1999) Effects of dopaminergic agents on antinociception in formalin test. Gen Pharmacol 32:517-522
48. Zhang ZD, Jin GZ, Xu SX, Yu LP, Chen Y, Jiang FY, Zhang YR, Sun Z, Ding YL, Bian CF et al (1986) Effects of l-stepholidine on the central nervous and cardiovascular systems. Zhongguo Yao Li Xue Bao 7:522-526
49. Zou LL, Liu J, Jin GZ (1997) Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats. Biochem Pharmacol 54:233-240